Business
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
NEW YORK, March 27, 2025--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production will
About this update from International Flavors & Fragrances, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":363,"url":"https://media.zenfs.com/en/business-wire.com/70fc838f4b8fff77fe81a55279d1b896"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/J_AzIs8VN2Pvl7Sdf8v17A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTcyNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/70fc838f4b8fff77fe81a55279d1b896","width":480,"height":363}},"lazy":false},{"type":"text","content":"Joint venture Alpha Bio will use IFF’s proprietary Designed Enzymatic Biomaterials™ technology to provide high-performance, sustainable alternatives to fossil-based ingredients","length":176,"tagName":"p"},{"type":"text","content":"NEW YORK, March 27, 2025--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production will use IFF’s Designed Enzymatic Biomaterial™ (DEB) platform technology, integrated at the IFF biorefinery in Kotka, Finland.","length":639,"tagName":"p"},{"type":"text","content":""Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers," said Erik Fyrwald, IFF CEO. "IFF’s DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also enhances performance across various applications. This innovative approach allows us to combine biodegradability and material sustainability while maintaining cost efficiency and the high performance our customers expect."","length":643,"tagName":"p"},{"type":"text","content":"IFF’s DEB platform leverages biotechnology by using plant-based sugars and enzymes under mild process conditions to create biobased materials, which can be tailored for specific product applications. This allows manufacturers to replace t...